scispace - formally typeset
K

Kaj-Erik Klaaborg

Researcher at Aarhus University Hospital

Publications -  25
Citations -  358

Kaj-Erik Klaaborg is an academic researcher from Aarhus University Hospital. The author has contributed to research in topics: Aortic valve & Aortic valve replacement. The author has an hindex of 10, co-authored 25 publications receiving 325 citations.

Papers
More filters
Journal ArticleDOI

Left ventricular global systolic longitudinal deformation and prognosis 1 year after femoral and apical transcatheter aortic valve implantation.

TL;DR: LV EF and longitudinal systolic deformation were improved in TAVI independent of technical approach using the Edwards SAPIEN valvehesis and the magnitude of changes in GLS seemed to have a prognostic impact.
Journal ArticleDOI

Fracturing the Ring of Small Mitroflow Bioprostheses by High-Pressure Balloon Predilatation in Transcatheter Aortic Valve-in-Valve Implantation

TL;DR: The first cases in vitro and in man of high-pressure balloon dilatation to fracture the ring of small dysfunctional Mitroflow aortic bioprostheses followed by transcatheter VIV implantation are reported.
Journal ArticleDOI

Extracorporeal membrane oxygenation in adult patients with severe acute respiratory failure

TL;DR: Outcome results are presented and whether or not simplified acute physiology score II (SAPS‐II), sequential organ failure assessment (SOFA) and/or Murray scores can be used to predict patients' outcome are investigated.
Journal ArticleDOI

High-pressure balloon fracturing of small dysfunctional Mitroflow bioprostheses facilitates transcatheter aortic valve-in-valve implantation.

TL;DR: Transcatheter BF-VIV is a promising alternative to repeat surgery in patients with small failing Mitroflow bioprosthesis and that it improves aortic valve haemodynamics and clinical functional capacity.
Journal ArticleDOI

Transapical transcatheter treatment of a stenosed aortic valve bioprosthesis using the Edwards SAPIEN Transcatheter Heart Valve.

TL;DR: A transapical treatment of a severely stenosed 21-mm aortic Mitroflow valve bioprosthesis is reported in an 82-year-old woman using a 23-mm Edwards SAPIEN Transcatheter Heart Valve.